Trial intelligence / Profile preview

AKP02 vs Enstilar in Mild to Moderate Psoriasis

NCT05249972Phase 3Unknown

Sponsor
Lipidor
Start
Jan 2022
Primary completion
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of calcipotriol + betamethasone in plaque psoriasis, sponsored by Lipidor. Status: unknown.

02

Drugs

calcipotriol + betamethasone
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT05249972.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05249972.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call